Old Web
English
Sign In
Acemap
>
authorDetail
>
Marc Wehrli
Marc Wehrli
Harvard University
Medicine
car t cells
Cancer research
Phase (matter)
Chimeric antigen receptor
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
2021
Blood
Matthew J. Frigault
Kathleen Gallagher
Marc Wehrli
Betsy Valles
Keagan S. Casey
Kevin Lindell
Michael Trailor
Hana Cho
Jami Brown
Nora Horick
Justin Chou
Rhine R. Shen
Simone Filosto
Adrian Bot
Marcela V. Maus
Show All
Source
Cite
Save
Citations (0)
Rational Chemical and Genetic Modifications Enhance Avidity and Function of CD70-Directed CAR-T-Cells for Myeloid Leukemia
2021
Blood
Mark B. Leick
Harrison Silva
Irene Scarfò
Rebecca C. Larson
Bryan D. Choi
Amanda A. Bouffard
Kathleen Gallagher
Andrea Schmidts
Stefanie R. Bailey
Michael Kann
Max Jan
Marc Wehrli
Korneel Grauwet
Matthew J. Frigault
Marcela V. Maus
Show All
Source
Cite
Save
Citations (1)
New CARs on and off the road: challenges and new developments in CAR-T cell therapy.
2021
Current Opinion in Pharmacology
Marc Wehrli
Marcela V. Maus
Show All
Source
Cite
Save
Citations (0)
Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies
2021
Blood
Matthew J. Frigault
Yi-Bin Chen
Kathleen Gallagher
Nora Horick
Areej El-Jawahri
Irene Scarfò
Marc Wehrli
Lu Huang
Keagan S. Casey
Daniella Cook
Thomas R. Spitzer
Steven L. McAfee
Frederic I. Preffer
Myriam Armant
Kit L. Shaw
Heather Daley
Sarah Nikiforow
Jerome Ritz
Marcela V. Maus
Show All
Source
Cite
Save
Citations (0)
1